Filters:
Investigator: Kevin Yarasheski1 Projects | 1 Researchers | $2,225,237 Invested
2020
C2N Diagnostics
Kevin Yarasheski, PhD
Clinical Validation and Accreditation for Plasma Aß42/Aß40 as a Biomarker for Alzheimer’s Disease Pathology
Kevin Yarasheski, PhD
Clinical Validation and Accreditation for Plasma Aß42/Aß40 as a Biomarker for Alzheimer’s Disease Pathology